139 related articles for article (PubMed ID: 33159679)
21. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
Hanczko R; Fernandez DR; Doherty E; Qian Y; Vas G; Niland B; Telarico T; Garba A; Banerjee S; Middleton FA; Barrett D; Barcza M; Banki K; Landas SK; Perl A
J Clin Invest; 2009 Jun; 119(6):1546-57. PubMed ID: 19436114
[TBL] [Abstract][Full Text] [Related]
22. Prenatal Diagnosis of Fetus With Transaldolase Deficiency Identifies Compound Heterozygous Variants: A Case Report.
Xue J; Han J; Zhao X; Zhen L; Mei S; Hu Z; Li X
Front Genet; 2021; 12():752272. PubMed ID: 35186000
[TBL] [Abstract][Full Text] [Related]
23. Liver Disease and Risk of Hepatocellular Carcinoma in Children With Mutations in TALDO1.
Grammatikopoulos T; Hadzic N; Foskett P; Strautnieks S; Samyn M; Vara R; Dhawan A; Hertecant J; Al Jasmi F; Rahman O; Deheragoda M; Bull LN; Thompson RJ;
Hepatol Commun; 2022 Mar; 6(3):473-479. PubMed ID: 34677006
[TBL] [Abstract][Full Text] [Related]
24. A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency.
Verhoeven NM; Wallot M; Huck JH; Dirsch O; Ballauf A; Neudorf U; Salomons GS; van der Knaap MS; Voit T; Jakobs C
J Inherit Metab Dis; 2005; 28(2):169-79. PubMed ID: 15877206
[TBL] [Abstract][Full Text] [Related]
25. Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum.
Banne E; Meiner V; Shaag A; Katz-Brull R; Gamliel A; Korman S; Cederboim SH; Duvdevani MP; Frumkin A; Zilkha A; Kapuller V; Arbell D; Cohen E; Eventov-Friedman S
JIMD Rep; 2016; 26():31-6. PubMed ID: 26238251
[TBL] [Abstract][Full Text] [Related]
26. Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency.
Huck JH; Struys EA; Verhoeven NM; Jakobs C; van der Knaap MS
Clin Chem; 2003 Aug; 49(8):1375-80. PubMed ID: 12881455
[TBL] [Abstract][Full Text] [Related]
27. Successful Liver Transplantation in Two Polish Brothers with Transaldolase Deficiency.
Stefanowicz M; Janowska M; Pawłowska J; Tylki-Szymańska A; Kowalski A; Szymczak M; Kaliciński P; Jankowska I
Children (Basel); 2021 Aug; 8(9):. PubMed ID: 34572178
[TBL] [Abstract][Full Text] [Related]
28. Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine.
Wamelink MM; Smith DE; Jansen EE; Verhoeven NM; Struys EA; Jakobs C
J Inherit Metab Dis; 2007 Oct; 30(5):735-42. PubMed ID: 17603756
[TBL] [Abstract][Full Text] [Related]
29. N-Acetylcysteine Therapy in an Infant with Transaldolase Deficiency Is Well Tolerated and Associated with Normalization of Alpha Fetoprotein Levels.
Rodan LH; Berry GT
JIMD Rep; 2017; 31():73-77. PubMed ID: 27130472
[TBL] [Abstract][Full Text] [Related]
30. Late diagnosis of a rare multisystemic genetic disorder: Transaldolase deficiency due to homozygous TALDO1 c.345dupA variant.
Dirim AB; Kalayci T; Safak S; Garayeva Guller N; Oto OA; Artan AS; Ozturk S; Yazici H
Nephrology (Carlton); 2024 Jan; 29(1):55-56. PubMed ID: 37740560
[No Abstract] [Full Text] [Related]
31. Long-Term Systematic Monitoring of Four Polish Transaldolase Deficient Patients.
Lipiński P; Pawłowska J; Stradomska T; Ciara E; Jankowska I; Socha P; Tylki-Szymańska A
JIMD Rep; 2018; 42():79-87. PubMed ID: 29292491
[TBL] [Abstract][Full Text] [Related]
32. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.
Huck JH; Verhoeven NM; Struys EA; Salomons GS; Jakobs C; van der Knaap MS
Am J Hum Genet; 2004 Apr; 74(4):745-51. PubMed ID: 14988808
[TBL] [Abstract][Full Text] [Related]
33. Chances of Liver Transplantation in a Patient With Transaldolase Deficiency Complicated by Hepatopulmonary Syndrome.
Fallata E; Alamri AM; Alrabee HA; Alghamdi AA; Alsaearei A
Cureus; 2023 Feb; 15(2):e35150. PubMed ID: 36949991
[TBL] [Abstract][Full Text] [Related]
34. Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.
Qian Y; Banerjee S; Grossman CE; Amidon W; Nagy G; Barcza M; Niland B; Karp DR; Middleton FA; Banki K; Perl A
Biochem J; 2008 Oct; 415(1):123-34. PubMed ID: 18498245
[TBL] [Abstract][Full Text] [Related]
35. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
Winans T; Oaks Z; Choudhary G; Patel A; Huang N; Faludi T; Krakko D; Nolan J; Lewis J; Blair S; Lai Z; Landas SK; Middleton F; Asara JM; Chung SK; Wyman B; Azadi P; Banki K; Perl A
J Autoimmun; 2023 Nov; 140():103112. PubMed ID: 37742509
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary manifestations in a patient with transaldolase deficiency.
Jassim N; Alghaihab M; Saleh SA; Alfadhel M; Wamelink MM; Eyaid W
JIMD Rep; 2014; 12():47-50. PubMed ID: 23846909
[TBL] [Abstract][Full Text] [Related]
37. The pathogenesis of transaldolase deficiency.
Perl A
IUBMB Life; 2007 Jun; 59(6):365-73. PubMed ID: 17613166
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.
Perl A; Hanczko R; Telarico T; Oaks Z; Landas S
Trends Mol Med; 2011 Jul; 17(7):395-403. PubMed ID: 21376665
[TBL] [Abstract][Full Text] [Related]
39. Characterization of non-oxidative transaldolase and transketolase enzymes in the pentose phosphate pathway with regard to xylose utilization by recombinant Saccharomyces cerevisiae.
Matsushika A; Goshima T; Fujii T; Inoue H; Sawayama S; Yano S
Enzyme Microb Technol; 2012 Jun; 51(1):16-25. PubMed ID: 22579386
[TBL] [Abstract][Full Text] [Related]
40. Transaldolase: from biochemistry to human disease.
Samland AK; Sprenger GA
Int J Biochem Cell Biol; 2009 Jul; 41(7):1482-94. PubMed ID: 19401148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
